Goldman Sachs’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$259K Sell
17,296
-3,880
-18% -$58K ﹤0.01% 4598
2025
Q1
$248K Sell
21,176
-16,882
-44% -$198K ﹤0.01% 4586
2024
Q4
$870K Sell
38,058
-3,107
-8% -$71K ﹤0.01% 3994
2024
Q3
$1.73M Buy
41,165
+28,110
+215% +$1.18M ﹤0.01% 3464
2024
Q2
$475K Sell
13,055
-61,032
-82% -$2.22M ﹤0.01% 3985
2024
Q1
$3.77M Buy
+74,087
New +$3.77M ﹤0.01% 2792
2022
Q4
Sell
-787
Closed -$10K 5287
2022
Q3
$10K Sell
787
-1,201
-60% -$15.3K ﹤0.01% 5254
2022
Q2
$41K Sell
1,988
-1,351
-40% -$27.9K ﹤0.01% 5318
2022
Q1
$126K Buy
3,339
+1,044
+45% +$39.4K ﹤0.01% 5242
2021
Q4
$222K Sell
2,295
-3,588
-61% -$347K ﹤0.01% 4936
2021
Q3
$850K Sell
5,883
-4,553
-44% -$658K ﹤0.01% 4091
2021
Q2
$1.93M Sell
10,436
-6,491
-38% -$1.2M ﹤0.01% 3530
2021
Q1
$4.17M Buy
16,927
+15,506
+1,091% +$3.82M ﹤0.01% 2808
2020
Q4
$400K Buy
1,421
+876
+161% +$247K ﹤0.01% 3947
2020
Q3
$131K Buy
+545
New +$131K ﹤0.01% 4166
2020
Q2
Sell
-5,376
Closed -$1.22M 4496
2020
Q1
$1.22M Buy
5,376
+4,611
+603% +$1.05M ﹤0.01% 3017
2019
Q4
$189K Buy
+765
New +$189K ﹤0.01% 4002
2018
Q4
Sell
-1,315
Closed -$77K 4189
2018
Q3
$77K Buy
+1,315
New +$77K ﹤0.01% 3987
2018
Q2
Sell
-528
Closed -$149K 4260
2018
Q1
$149K Sell
528
-40,041
-99% -$11.3M ﹤0.01% 3944
2017
Q4
$9.54M Sell
40,569
-7,588
-16% -$1.78M ﹤0.01% 1928
2017
Q3
$13.7M Buy
48,157
+12
+0% +$3.41K ﹤0.01% 1801
2017
Q2
$13.5M Sell
48,145
-247
-0.5% -$69.5K ﹤0.01% 1773
2017
Q1
$16.2M Sell
48,392
-49
-0.1% -$16.4K ﹤0.01% 1621
2016
Q4
$16M Sell
48,441
-1,139
-2% -$376K ﹤0.01% 1594
2016
Q3
$13.2M Buy
49,580
+1,722
+4% +$460K ﹤0.01% 1695
2016
Q2
$6.34M Sell
47,858
-658
-1% -$87.1K ﹤0.01% 2003
2016
Q1
$8.56M Buy
48,516
+47,614
+5,279% +$8.4M ﹤0.01% 1813
2015
Q4
$225K Buy
+902
New +$225K ﹤0.01% 3668